PR91455

YICHANG, China, Sept. 2, 2021 /PRNewswire=KYODO JBN/ --

Angel Yeast Co., Ltd (http://en.angelyeast.com/)("Angel Yeast" or "Angel"), a

listed high-tech yeast company in China, announced its nutritional R&D team has

developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S.

boulardii Bld-3)(https://en.angelyeast.com/products/human-health/saccharomyces-boulardii.h

tml), and an innovative production technology for the new product. The patented

yeast probiotic is designed to treat diarrhea and strengthen healthy digestive

and immune systems in children and adults.

"Saccharomyces boulardii (S. boulardii) is a kind of probiotic that has been

considered a crucial nutritional intervention in treating diarrhea. The new

strain of yeast probiotic developed by Angel Nutrition & Health Technical

Center, S. boulardii Bld-3, is another ground-breaking addition to the S.

boulardii family that has been proven effective in speeding up recovery from

acute diarrhea and is beneficial to intestinal health in the long term," said

Dr. Zhang Yan, CTO of Angel Nutritech, established in 1992 by Angel Yeast

focusing on human nutrition & health to develop and supply featured finished

products to global human care industries.

COVID-19 has prompted more people to pay attention to their health and an

increased focus on precautionary measures and healthcare products that prevent

diseases and support their immune systems. On Google Trends, the search queries

"gut health" and "probiotic" have seen several spikes during the pandemic. For

gastrointestinal healthcare, keyword searches related to probiotics also

climbed to a record high this year, signaling increased recognition of its

robust ability to restore and maintain a healthy digestive system for humans.

The use of S. boulardii for management of adult and children with diarrhea has

been widely prescribed by doctors and gastroenterologists for decades and its

efficacy for combating an array of gastrointestinal conditions is well

documented in medical literature. A study published in the Chinese Journal of

Pediatrics (https://pubmed.ncbi.nlm.nih.gov/27938588/) concludes that certain

types of probiotics can reduce the severity and duration of diarrhea. Among

them, Lactobacillus rhamnosus GG and S. boulardii are the two most effective

probiotics for anti-diarrhea treatment.

Unlike Lactobacillus probiotics, Angel's S. boulardii Bld-3 is developed using

the low-temperature fluidized bed process. The company's unique protection

technology allows it to quickly form a dense yeast shell that encloses active

yeast probiotics entrapped inside. This process strengthens the yeast's

resistance to gastric acid and bile salts, enabling it to be applied in a wide

variety of end probiotic products.

Angel's S. boulardii Bld-3 is a suitable ingredient for wide-ranging probiotic

dietary supplements. Thanks to the larger size of yeast probiotics, which is

ten times as big as that of Lactobacillus probiotics, they are more likely to

form a space-occupying effect in the intestinal tract and are resistant to

antibiotics.

One of the world's largest suppliers of yeast derivatives, Angel Yeast has over

three decades of experience in the development and production of yeast

products. In addition to S. boulardii Bld-3, Angel Yeast also produces

Saccharomyces cerevisiae probiotic and other extensive ranges of functional

yeast ingredients, with several new products in the pipeline including

Kluyveromyces marxianus. At present, probiotic products produced by Angel Yeast

have been sold to Europe and North America.

About Angel Yeast

Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast

and yeast derivatives. Its product range includes baker's yeast and

ingredients, Chinese dim sum solutions, yeast extract-savory, human health,

animal nutrition, plant care, brewing & biofuels, microbial nutrition, and

enzymes. At present, Angel Yeast has 11 international advanced production bases

in China, Egypt, and Russia, and provides products and services for more than

150 countries and regions globally.

Source: Angel Yeast

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=399783

   Caption: Angel Yeast announced it has developed a new strain of yeast probiotic,

Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) to treat diarrhea and

strengthen healthy digestive and immune systems in children and adults.